Asia Pac Allergy.  2012 Jul;2(3):227-229. 10.5415/apallergy.2012.2.3.227.

Chronic urticaria and use of statins

• Khan S

• KMID: 2397486
• DOI: http://doi.org/10.5415/apallergy.2012.2.3.227

Abstract

No abstract available.

MeSH Terms

Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Urticaria*

Reference

1. Chow SK. Management of chronic urticaria in Asia: 2010 AADV consensus guidelines. Asia Pac Allergy. 2012; 2:149–160. PMID: 22701866.

2. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Giménez-Arnau AM, Grattan CE, Kapp A, Maurer M, Merk HF, Rogala B, Saini S, Sánchez-Borges M, Schmid-Grendelmeier P, Schünemann H, Staubach P, Vena GA, Wedi B. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy. 2009; 64:1427–1443. PMID: 19772513.

3. Godse KV, Zawar V, Krupashankar D, Girdhar M, Kandhari S, Dhar S, Ghosh S, Rajagopalan M, Zuberbier T. Consensus statement on the management of urticaria. Indian J Dermatol. 2011; 56:485–489. PMID: 22121259.

4. Inman WH, Rawson NS, Wilton LV, Pearce GL, Speirs CJ. Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring. BMJ. 1988; 297:826–829. PMID: 2846101.

5. Pfeiffer C. Chronic urticaria and angioedema. N Engl J Med. 2002; 347:220–222. author reply 220-2. PMID: 12132108.

6. Kaplan AP. Clinical practice. Chronic urticaria and angioedema. N Engl J Med. 2002; 346:175–179. PMID: 11796852.

7. Moulis G, Béné J, Sommet A, Sailler L, Lapeyre-Mestre M, Montastruc JL. Statin-induced lupus: a case/non-case study in a nationwide pharmacovigilance database. Lupus. 2012; 21:885–889. PMID: 22333565.

8. Knapp AC, Huang J, Starling G, Kiener PA. Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death. Atherosclerosis. 2000; 152:217–227. PMID: 10996358.

9. Noël B. Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review. J Eur Acad Dermatol Venereol. 2007; 21:17–24. PMID: 17207162.

10. Youssef S, Stüve O, Patarroyo JC, Ruiz PJ, Radosevich JL, Hur EM, Bravo M, Mitchell DJ, Sobel RA, Steinman L, Zamvil SS. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature. 2002; 420:78–84. PMID: 12422218.